Grossi, F
Rijavec, E
Genova, C
Barletta, G
Biello, F
Maggioni, C
Burrafato, G
Sini, C
Dal Bello, M G
Meyer, K
Roder, J
Roder, H
Grigorieva, J
Article History
Received: 26 May 2016
Revised: 24 September 2016
Accepted: 31 October 2016
First Online: 29 November 2016
Competing interests
: Julia Grigorieva, Krista Meyer, Joanna Roder, and Heinrich Roder are employees of Biodesix and hold company options. Francesco Grossi was compensated as a speaker for Eli Lilly, Bristol-Myers-Squibb, and received fees for participating in sponsored meetings and advisory boards of Bristol-Myers-Squibb. Carlo Genova received personal fees from Bristol-Myers-Squibb. The remaining authors declare no conflict of interest.